Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of PNT2258 for Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
ProNAi Therapeutics, Inc
ClinicalTrials.gov Identifier:
NCT01733238
First received: November 20, 2012
Last updated: June 2, 2016
Last verified: June 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)